Mindy B. Leathe

Mindy B. Leathe

Areas of Concentration

· Tax

· Employee benefits

· Executive compensation planning

Significant Representations

· Represented California Higher Education Loan Authority (CHELA) in completing a more than $2.4 billion recapitalization, restructuring and spin-off transaction. As a result, CHELA (now The Education Financing Foundation of California) became the largest education financing foundation in the State of California.

· Represented PolyMedica Corporation, in connection with the sale of its Women's Health Products Division to Amerifit Nutririon, Inc. for $45 million.

· Represented Trendum Ltd. in connection with its acquisition of PulpFree, Inc.

· Represented the stockholders of Amide Holdings, Inc. and its wholly-owned subsidiary, Amide Pharmaceutical, Inc., a privately owned U.S. generic pharmaceuticals company ("Amide"), in the acquisition of Amide by Actavis Group hf, a publicly traded global generic pharmaceutical company listed on the Iceland Stock Exchange and headquartered in Iceland.

· Advising clients with regard to qualified and non-qualified deferred compensation plans, including 401(k) plans, employee stock purchase plans, health and welfare plans, and other employee benefit plan issues.

· Advising emerging and publicly-held clients with respect to executive compensation techniques and strategies, including stock options, restricted stock and other forms of equity compensation, executive employment agreements and compensation, split dollar insurance arrangements, and change in control severance agreements.

· Advising clients with regard to various employee benefit plan issues relating to corporate mergers and acquisitions.

Awards & Recognition

· Latin Lawyer Magazine, M&A Deal of the Year Award, 2008